Close

ARIAD Reports Third Quarter 2011 Financial Results and Development Progress Nov 3, 2011 07:35AM
Notable Analyst Rating Changes 05/25: (HAL) (BSX) (AVGO) Upgraded; (JNPR) (SAPE) (NETL) Downgraded May 25, 2011 10:38AM
Brean Murray Carret & Co. Assumes Coverage on ARIAD Pharmaceuticals (ARIA) at Buy, $11 Price Target May 25, 2011 10:18AM
Brean Murray Issuses Mid-Day Upgrade on ARIAD Pharma (ARIA); Stock Trades to Intraday Highs May 5, 2010 03:09PM
Brean Murray Initiates Coverage on Ariad Pharmaceuticals (ARIA) with a Hold; Strong Fundamentals, Cautious on Phase 3 Trial Oct 8, 2009 08:36AM